Eva A.H. Lanters

1.0k total citations
39 papers, 757 citations indexed

About

Eva A.H. Lanters is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Eva A.H. Lanters has authored 39 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Eva A.H. Lanters's work include Cardiac electrophysiology and arrhythmias (25 papers), Cardiac Arrhythmias and Treatments (24 papers) and Atrial Fibrillation Management and Outcomes (24 papers). Eva A.H. Lanters is often cited by papers focused on Cardiac electrophysiology and arrhythmias (25 papers), Cardiac Arrhythmias and Treatments (24 papers) and Atrial Fibrillation Management and Outcomes (24 papers). Eva A.H. Lanters collaborates with scholars based in Netherlands, United States and India. Eva A.H. Lanters's co-authors include Natasja M.S. de Groot, Ad J.J.C. Bogers, Charles Kik, Paul Knops, Christophe P. Teuwen, Maurits A. Allessie, Bianca J.J.M. Brundel, Ameeta Yaksh, Denise M.S. van Marion and Lisette J.M.E. van der Does and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Eva A.H. Lanters

38 papers receiving 749 citations

Peers

Countries citing papers authored by Eva A.H. Lanters

Since Specialization

Citations

This map shows the geographic impact of Eva A.H. Lanters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva A.H. Lanters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva A.H. Lanters more than expected).

Fields of papers citing papers by Eva A.H. Lanters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva A.H. Lanters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva A.H. Lanters. The network helps show where Eva A.H. Lanters may publish in the future.

Co-authorship network of co-authors of Eva A.H. Lanters

This figure shows the co-authorship network connecting the top 25 collaborators of Eva A.H. Lanters. A scholar is included among the top collaborators of Eva A.H. Lanters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva A.H. Lanters. Eva A.H. Lanters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2 2022 ·Journal of the American Heart Association ·(unknown), Qi Xi, (unknown), Eva A.H. Lanters, Jaap Keijer, Natasja M.S. de Groot, Bianca J.J.M. Brundel, Deli Zhang	15
2	Atrial heat shock protein levels are associated with early postoperative and persistence of atrial fibrillation 2021 ·Heart Rhythm ·Denise M.S. van Marion, (unknown), Eva A.H. Lanters, (unknown), Ad J.J.C. Bogers, Natasja M.S. de Groot, Bianca J.J.M. Brundel	7
3	Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation 2020 ·Cells ·Denise M.S. van Marion, Eva A.H. Lanters, (unknown), Jin Li, Marit Wiersma, (unknown), A Muskens, Eric Boersma, Natasja M.S. de Groot, Bianca J.J.M. Brundel	22
4	Blood-based 8-hydroxy-2′-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation 2020 ·Heart Rhythm ·(unknown), Deli Zhang, (unknown), (unknown), Marit Wiersma, Eva A.H. Lanters, Ad J.J.C. Bogers, Natasja M.S. de Groot, Bianca J.J.M. Brundel	25
5	Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation 2020 ·Cells ·Marit Wiersma, Denise M.S. van Marion, (unknown), Jin Li, Deli Zhang, (unknown), Eva A.H. Lanters, Natasja M.S. de Groot, Bianca J.J.M. Brundel	43
6	DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation 2019 ·Nature Communications ·Deli Zhang, Xu Hu, (unknown), Jia Liu, (unknown), Marit Wiersma, (unknown), Denise M.S. van Marion, (unknown), Femke Hoogstra‐Berends, Eva A.H. Lanters, Arie M. van Roon, Antoine A.F. de Vries, Daniël A. Pijnappels, Natasja M.S. de Groot, Robert H. Henning, Bianca J.J.M. Brundel	114
7	Ventricular Dysrhythmias During Long-Term Follow-Up in Patients With Inherited Cardiac Arrhythmia 2019 ·The American Journal of Cardiology ·(unknown), Ahmed A.Y. Ragab, Charlotte A. Houck, Eva A.H. Lanters, (unknown), (unknown), A Muskens, Natasja M.S. de Groot	4
8	The Effects of Valvular Heart Disease on Atrial Conduction During Sinus Rhythm 2019 ·Journal of Cardiovascular Translational Research ·Lisette J.M.E. van der Does, Eva A.H. Lanters, Christophe P. Teuwen, (unknown), Ameeta Yaksh, Paul Knops, Charles Kik, Ad J.J.C. Bogers, Natasja M.S. de Groot	9
9	QRS Vector Magnitude as Predictor of Ventricular Arrhythmia in Patients With Brugada Syndrome 2019 ·The American Journal of Cardiology ·Ahmed A.Y. Ragab, Charlotte A. Houck, Lisette J.M.E. van der Does, Eva A.H. Lanters, A Muskens, Natasja M.S. de Groot	4
10	The impact of obesity on early postoperative atrial fibrillation burden 2019 ·Journal of Thoracic and Cardiovascular Surgery ·Maria-Corina Șerban, (unknown), (unknown), Eva A.H. Lanters, Ameeta Yaksh, Charles Kik, (unknown), Paul Knops, Ad J.J.C. Bogers, Natasja M.S. de Groot	12
11	Application of kinomic array analysis to screen for altered kinases in atrial fibrillation remodeling 2018 ·Heart Rhythm ·Roelien A. M. Meijering, Marit Wiersma, Deli Zhang, Eva A.H. Lanters, Femke Hoogstra‐Berends, (unknown), Sander H. Diks, (unknown), Natasja M.S. de Groot, Stanley Nattel, Robert H. Henning, Bianca J.J.M. Brundel	4
12	Impact of the arrhythmogenic potential of long lines of conduction slowing at the pulmonary vein area 2018 ·Heart Rhythm ·(unknown), Lisette J.M.E. van der Does, Charles Kik, Eva A.H. Lanters, Christophe P. Teuwen, Paul Knops, Ad J.J.C. Bogers, Natasja M.S. de Groot	13
13	Aberrant coronary artery spasms cause ST‐T segment depression during endovascular ablation of atrial flutter 2017 ·Clinical Case Reports ·Eva A.H. Lanters, Adriaan Coenen, Marisa M. Lubbers, Koen Nieman, Natasja M.S. de Groot	0
14	Spatial distribution of conduction disorders during sinus rhythm 2017 ·International Journal of Cardiology ·Eva A.H. Lanters, Ameeta Yaksh, Christophe P. Teuwen, Lisette J.M.E. van der Does, Charles Kik, Paul Knops, Denise M.S. van Marion, Bianca J.J.M. Brundel, Ad J.J.C. Bogers, Maurits A. Allessie, Natasja M.S. de Groot	24
15	Usefulness of the R-Wave Sign as a Predictor for Ventricular Tachyarrhythmia in Patients With Brugada Syndrome 2017 ·The American Journal of Cardiology ·Ahmed A.Y. Ragab, Charlotte A. Houck, Lisette J.M.E. van der Does, Eva A.H. Lanters, (unknown), A Muskens, Natasja M.S. de Groot	10
16	Impact of Supraventricular Tachyarrhythmia in Patients With Inherited Cardiac Arrhythmia 2017 ·The American Journal of Cardiology ·Ahmed A.Y. Ragab, Charlotte A. Houck, Lisette J.M.E. van der Does, Eva A.H. Lanters, A Muskens, Natasja M.S. de Groot	1
17	Pharmacological Therapy of Tachyarrhythmias During Pregnancy 2016 ·Arrhythmia & Electrophysiology Review ·Ameeta Yaksh, (unknown), Eva A.H. Lanters, Natasja M. De Groot	12
18	QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design 2016 ·Journal of Cardiovascular Translational Research ·Lisette J.M.E. van der Does, Ameeta Yaksh, Charles Kik, Paul Knops, Eva A.H. Lanters, Christophe P. Teuwen, Frans B S Oei, Pieter C. van de Woestijne, Jos A. Bekkers, Ad J.J.C. Bogers, Maurits A. Allessie, Natasja M.S. de Groot	35
19	HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation 2015 ·Journal of Translational Medicine ·Eva A.H. Lanters, Denise M.S. van Marion, Charles Kik, (unknown), Ad J.J.C. Bogers, Maurits A. Allessie, Bianca J.J.M. Brundel, Natasja M.S. de Groot	38
20	The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line 2015 ·Netherlands Heart Journal ·Eva A.H. Lanters, Denise M.S. van Marion, (unknown), Natasja M.S. de Groot, Bianca J.J.M. Brundel	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact